Gilead Sciences Inc (GILD) Insider Trading
- $1,429,700.00
- $1,101,978,734.71
- May 22, 2025
- John C Martin
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 26, 2014 | Director | 20,000 | $84.05 | Sell | $1,681,000.00 | |
| Feb. 19, 2014 | Director | 19,068 | $83.12 | Sell | $1,584,932.16 | |
| Jan. 23, 2014 | EVP | 100,000 | $81.44 | Sell | $8,144,000.00 | |
| Jan. 21, 2014 | EVP | 120,000 | $80.00 | Sell | $9,600,000.00 | |
| Jan. 14, 2014 | EVP | 90,000 | $74.23 | Sell | $6,680,700.00 | |
| Oct. 23, 2013 | EVP | 75,000 | $68.56 | Sell | $5,142,000.00 | |
| Oct. 14, 2013 | EVP | 90,000 | $62.54 | Sell | $5,628,600.00 | |
| Sept. 23, 2013 | EVP | 100,000 | $62.88 | Sell | $6,288,000.00 | |
| Sept. 16, 2013 | EVP | 90,000 | $63.11 | Sell | $5,679,900.00 | |
| Sept. 3, 2013 | CEO | 282,242 | $60.97 | Sell | $17,208,294.74 | |
| Sept. 3, 2013 | EVP | 30,000 | $60.99 | Sell | $1,829,700.00 | |
| Aug. 30, 2013 | Director | 151,720 | $60.42 | Sell | $9,166,922.40 | |
| Aug. 14, 2013 | EVP | 90,000 | $58.77 | Sell | $5,289,300.00 | |
| Aug. 1, 2013 | EVP | 30,000 | $61.49 | Sell | $1,844,700.00 | |
| Aug. 1, 2013 | CEO | 282,242 | $61.61 | Sell | $17,388,929.62 | |
| July 30, 2013 | Director | 249,000 | $61.97 | Sell | $15,430,530.00 | |
| July 15, 2013 | EVP | 90,000 | $57.33 | Sell | $5,159,700.00 | |
| July 2, 2013 | Director | 17,000 | $51.66 | Sell | $878,220.00 | |
| July 1, 2013 | CFO | 45,600 | $52.01 | Sell | $2,371,656.00 | |
| July 1, 2013 | EVP | 30,000 | $52.09 | Sell | $1,562,700.00 | |
| July 1, 2013 | CEO | 282,242 | $52.00 | Sell | $14,676,584.00 | |
| June 7, 2013 | Director | 110,000 | $52.15 | Sell | $5,736,500.00 | |
| June 3, 2013 | EVP | 30,000 | $52.77 | Sell | $1,583,100.00 | |
| June 3, 2013 | CEO | 282,242 | $52.84 | Sell | $14,913,667.28 | |
| Feb. 28, 2013 | Director | 10,000 | $43.05 | Buy | $430,500.00 | |
| Dec. 3, 2012 | EVP | 44,000 | $75.10 | Sell | $3,304,400.00 | |
| Dec. 3, 2012 | CEO | 291,000 | $75.01 | Sell | $21,827,910.00 | |
| Nov. 12, 2012 | CFO | 55,950 | $73.11 | Sell | $4,090,504.50 | |
| Oct. 3, 2012 | COO | 140,000 | $69.85 | Sell | $9,779,000.00 | |
| Oct. 2, 2012 | CFO | 29,500 | $68.62 | Sell | $2,024,290.00 | |
| Sept. 4, 2012 | EVP | 44,000 | $57.50 | Sell | $2,530,000.00 |
Insiders are both buying and selling Gilead Sciences Inc stock.
The insider traders at Gilead Sciences Inc are: John C Martin, John Francis Cogan, Gregg H Alton, Brett A Pletcher, Paul Rutherford Carter, Robin L Washington, Andrew D Dickinson, John F Milligan, Merdad Parsey, Richard James Whitley, Norbert Bischofberger, John C. Martin, Norbert W Bischofberger, Gregg Alton, Gregg H. Alton, Johanna Mercier, Gayle E Wilson, John Martin, Olsen Per Wold, Diane E Wilfong, Nicholas Moore, Kevin Young, John F. Milligan, John W Madigan, Robin Washington, Norbert W. Bischofberger, James R Meyers, Jeffrey Bluestone, Javier Rodriguez, Kevin E Lofton, Diane E. Wilfong, Marjorie Taylor Greene, Nicholas G Moore, and Gayle E. Wilson
The most active insider trader at Gilead Sciences Inc is John C Martin with 41 trades.
John C Martin has sold the most Gilead Sciences Inc stock with a total value of $373,177,431.55.
Olsen Per Wold has bought the most Gilead Sciences Inc stock with a total value of $2,428,900.00.
The most recent insider trade for Gilead Sciences Inc was on May 22, 2025.
The single biggest insider buy for Gilead Sciences Inc was from Olsen Per Wold with a total value of $999,200.00 on Feb. 6, 2015.
The single biggest insider sell for Gilead Sciences Inc was from Andrew D Dickinson with a total value of $23,064,310.20 on Nov. 29, 2024.